HOME >> MEDICINE >> NEWS
Eye drops can delay onset of glaucoma

St. Louis, June 13, 2002 -- A study led by investigators at Washington University School of Medicine in St. Louis has found that drops that lower eye pressure can delay the onset of glaucoma. The eye drops reduced the development of open-angle glaucoma by more than 50 percent. The study appears in the June 2002 issue of the Archives of Ophthalmology.

The fundamental question we asked was whether you can delay or prevent people from developing glaucoma, says Michael A. Kass, M.D., national chair of the 22-center study and head of the Department of Ophthalmology and Visual Sciences at Washington University School of Medicine. There are millions of people in the United States and in other countries who are at risk of developing glaucoma because they have high pressure in their eyes. This study provides the first good evidence that treating those people may delay, or possibly even prevent, the blinding eye disease, glaucoma.

The study, called the Ocular Hypertension Treatment Study (OHTS), examined 1,636 people between the ages of 40 and 80. All had elevated pressure in the eye ocular hypertension but did not have glaucoma. About half (817) were randomly selected to use eye drops each day. The other patients (819) were closely monitored by eye specialists for a minimum of five years. Patients who received treatment were given commercially available, pressure-lowering eye drops, either a single type of drop or a combination of more than one. The drops reduced pressure in the eye by approximately 20 percent.

I think it is very significant that reducing pressure in the eye by only 20 percent reduced risk by as much as it did, Kass says. A modest drop in pressure makes a big difference.

Open-angle glaucoma is the most common form of glaucoma and one of the leading causes of blindness in the United States. It is the number one cause of blindness among African Americans and affects a total of about 2.2 million Americans age 40 and ove
'"/>

Contact: Jim Dryden
drydenj@msnotes.wustl.edu
314-286-0100
Washington University School of Medicine
13-Jun-2002


Page: 1 2 3 4

Related medicine news :

1. Weekend use matches daily drops for lazy eye
2. New ways identified to treat lazy eye in children: Beyond eye patches and daily drops
3. Eye drops may delay or prevent glaucoma in African Americans at higher risk
4. Unexpected similarities between raindrops and proteins
5. Infant mortality rate drops, children more likely to have working parent, be read to
6. Eye drops delay onset of glaucoma in people at higher risk
7. UC Davis study shows eye drops delay onset of glaucoma in people at higher risk
8. Study shows eye drops useful in preventing glaucoma
9. First quarter 2002 prescription drug spending: Higher again, but rate of increase drops
10. Eye drops to treat childhood eye disorder work as well as patching the eye
11. Study finds drops work as well as patch for lazy eye

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Eye drops can delay onset glaucoma

(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... 25, 2013 The latest report ... irritable bowel syndrome (IBS) to bloating, constipation, diarrhea ... most long-lasting, embarrassing, frustrating and difficult health issues ... digestive health have provided a cure for ... factors contributing to digestive health issues, a healthy ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... 2013 According to world-renowned scholars, Queen ... powerful women that ever lived. Cleopatra’s legendary beauty moved ... the most powerful men in her time. Cleopatra was ... keep her skin glowing and fresh, from her legendary ... maringa oil and cyprus grass. , Cleopatra was said ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... In accordance with Rule 17.1 and Rule 2.9 ... United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") ... (NYSE: ELN). Background On 2 May ... for the entire of the issued and to be issued ... On 20 May 2013, Royalty Pharma announced ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
Cached News: